Showing results (341-350 of 389) with videos related to

Sort By:
Pageof 39
Orphanet Journal of Rare Diseases|September 17, 2013
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylaseJohannes Hofland, Leo J Hofland, Peter M van Koetsveld, et al.
Endocrine-Related Cancer|August 19, 2016
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomasS G Creemers, P M van Koetsveld, F J van Kemenade, et al.
Annals of Surgery|March 4, 2017
Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study GroupSjoerd Nell, Helena M Verkooijen, Carolina R C Pieterman, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2014
Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patientsJoanne M de Laat, Carolina R Pieterman, Medard F van den Broek, et al.
Lancet (London, England)|June 8, 2024
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 studySimron Singh, Daniel Halperin, Sten Myrehaug, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trialM H Kulke, P Ruszniewski, E Van Cutsem, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2016
Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Bernadette P M van Nesselrooij, Ad R Hermus, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study GroupRachel S van Leeuwaarde, Koen M Dreijerink, Margreet G Ausems, et al.
BMC Medicine|November 16, 2016
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsJoanne M de Laat, Rob B van der Luijt, Carolina R C Pieterman, et al.
Journal of Surgical Oncology|August 12, 2019
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)Dirk-Jan van Beek, Sjoerd Nell, Carolina R C Pieterman, et al.
Pageof 39